baber/WOPTO huggingface dataset:
Patent AU-2020201665-A1 (AU)
Title: Wireless power transfer and communications for industrial equipment
Inventor: NAGLE GREGORY A
IPC: B66F9/18
Filed: 2020-03-05
Abstract: Abstract Methods and systems for wirelessly transmitting power and/or data, using an inductive power transfer unit (110) comprising an inductive power transmitter (118) and an inductive power receiver (120). Preferably, the inductive power transmitter (118) is capable of receiving power from a power source and transmitting it wirelessly and inductively to the inductive power receiver (120), which in turn delivers power to power consuming devices (158). More preferably, the inductive power receiver is capable of delivering power to the power consuming devices (158) even when it is not receiving inductive power from the wireless power transmitter. To be published with FIG. 1 0 0 C j CN 0 7 i C) i 1 CN . Ll co I 9-1 i 0 r 0 co k k
Patent AU-2020202393-A1 (AU)
Title: This invention will combine the operating system principles of High Volume Processing methods and robotics to operate as an abattoir refitted into an airship in order to operate in remote and isolated areas of Australia. This will provide graziers with a local cluster or individual onsite processing facility and remove the cost of transporting stock
Inventor: GOODWIN GREGORY KEITH
IPC: G06Q10/06
Filed: 2020-04-05
Abstract: (57) 
This invention will combine the operating system principles of High Volume Processing methods and 
robotics to operate as an abattoir refitted into an airship in order to operate in remote and isolated 
areas of Australia. This will provide graziers with a local cluster of individual onsite processing facility 
and remove the cost of transporting stock.
Patent AU-2020202784-A1 (AU)
Title: Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl) methyl)urea hydrochloride and compositions, methods and kits related thereto
Inventor: HUNT III STEPHEN WARREN
IPC: A61K31/17
Filed: 2020-04-27
Abstract: :1\Interwovn\NRPortbl\DCCSXD\20129404_l.docx-27/04/2020 A novel solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4 (dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride (also referred to "ATR 101") suitable for oral dosing, and to compositions, methods and kits relating thereto. ATR-101 has particular utility in the treatment of, for example, aberrant adrenocortical cellular activity, including adrenocortical carcinoma (ACC), congenital adrenal hyperplasia (CAH) and Cushing's syndrome. - 53-
Patent AU-2020204125-A1 (AU)
Title: End Cap Arrangement for a Shutter
Inventor: O'KEEFFE STEPHEN JOHN
IPC: E06B7/086
Filed: 2020-06-19
Abstract: An end cap arrangement (18) for locating a shutter blade (12) with a frame (14), the 
end cap arrangement (18) includes an end cap (24) having an end cap body (26) 
arranged to locate with an end (25) of the shutter blade and a pivot (30) arranged to 
extend from the end cap body (26) so as to engage with the frame (14) in a fitted 
condition, wherein the pivot (30) is biased so as to urge the end cap body (24) toward 
the shutter blade (12) in the fitted condition. A coupling assembly (16) including an end 
cap arrangement (18), a shutter assembly (10) including an end cap arrangement (18), 
and an associated method of use are also disclosed.
Patent AU-2020208357-A1 (AU)
Title: High load dispersions and uses thereof
Inventor: SUPAMAHITORN JAI
IPC: A23K10/30
Filed: 2020-01-15
Abstract: The present disclosure relates to high load dispersions and uses thereof. In particular, the present disclosure provides high load dispersions for use in preventing and treating disease in calves, cattle, and other animals.
Patent AU-2020208360-A1 (AU)
Title: Method and system of identifying and quantifying antibody fragmentation
Inventor: YAN YUETIAN
IPC: G01N30/88
Filed: 2020-01-15
Abstract: Methods for identifying and quantifying antibody fragments and identifying the site of fragmentation on an antibody in a sample comprising the steps of loading a sample including fragments of the antibody into a chromatography system having a mixed-mode size-exclusion stationary phase (110), washing said mixed-mode size-exclusion stationary phase using a mobile phase to provide an eluent comprising said fragments, determining the molecular weight of said fragments using a mass spectrometer (120), and correlating said molecular weight to known protein standards.
Patent AU-2020218769-A1 (AU)
Title: Inter-intra prediction mode for video data
Inventor: PHAM VAN LUONG
IPC: H04N19/107
Filed: 2020-02-05
Abstract: An example device for coding (encoding or decoding) video data includes a memory for storing video data and one or more processors implemented in circuitry and configured to form an inter-prediction block for a current chrominance block of the video data; form an intra-prediction block for the current chrominance block of the video data; determine a number of neighboring blocks to a luminance block corresponding to the current chrominance block that are intra-prediction coded; determine a first weight and a second weight according to the number of neighboring blocks that are intra-prediction coded; apply the first weight to the inter-prediction block and the second weight to the intra-prediction block; combine the first weighted inter- prediction block and the second weighted intra-prediction block to form a prediction block for the current chrominance block; and code the current chrominance block using the prediction block.
Patent AU-2020221834-A1 (AU)
Title: Genotype and dose-dependent response to an ASBTI in patients with bile salt export pump deficiency
Inventor: JAECKLIN THOMAS
IPC: A61P1/16
Filed: 2020-02-12
Abstract: Provided herein are methods for treating or ameliorating cholestatic liver disease in a subject in need thereof. The methods include administering an Apical Sodium-dependent Bile Acid Transport Inhibitor (ASBTI) to the subject. The methods include determining a genotype of the subject and predicting subject response to the ASBTI administration based upon the genotype. The methods further include determining, adjusting, or modulating a dose of the ASBTI administered to the subject based upon the genotype or upon measurements of clinically relevant disease parameters.
Patent AU-2020223670-A1 (AU)
Title: Desiccant product mounting for electrical installations
Inventor: GUINEA JOSEPH KENT
IPC: H02B1/28
Filed: 2020-08-25
Abstract: The invention relates to a desiccant mounting device for IP Rated electrical 
installations. The desiccant mounting device includes a chamber for containing 
desiccant, an opening in the chamber, and an attachment means, for attaching the 
chamber at a suitable predetermined location, within or about the electrical 
installation suitable to expose the desiccant to moisture to be removed. The 
desiccant mounting device substantially facilitates the installation and replacement 
of the desiccant within or about of the electrical installation and the electrical 
installation and desiccant mounting device maintain the IP Rating, once installed.  
The invention also relates to variants thereon, and methods of use.
2/4 
22 
14 
21 
0 
10 
1,2 
28 
18 
16 
24 
26 
FIGURE 2
Patent AU-2020228072-A1 (AU)
Title: Tape winch, drilling progress measurement and hole depth measurement
Inventor: STEWART GORDON
IPC: E21B19/02
Filed: 2020-02-27
Abstract: Winch (304) has a load bearing tape (305) to advance into a borehole (307). Hole depth can be determined by subtracting a sensed height (310) above ground surface (311) from total depth (312) measured. Can include a height above ground sensor (314) and a tape distance measurer (316). Depth of water or watery mud or muddy water (320) can be sensed, such as by a pressure sensor (326) on a weight or in a sensor device at or near the tape leading end. A heater (309) can warm the tape. A cover or housing (313) can be provided for the winch or spool. The tape can include wires or fibre optics (336) embedded in or applied to a surface of the tape (305) and/or apertures or embedded or surface applied markers/indicators (338) along a length thereof e.g. for reading by an optical or magnetic sensor.
Patent AU-2020246880-A1 (AU)
Title: Fungicide formulations with reduced crystal growth
Inventor: CAPUZZI GIULIA
IPC: A01N25/30
Filed: 2020-02-24
Abstract: This invention relates to a composition comprising a compound of formula (I) and an agrochemical active ingredient selected from ADEPIDYN™ (pydiflumetofen), oxathiapiprolin, sedaxane and azoxystrobin; R
Patent AU-2020273302-A1 (AU)
Title: Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
Inventor: VENKATESAN ARANAPAKAM M
IPC: C07D403/04
Filed: 2020-11-19
Abstract: The present application provides novel heterocyclic compounds and pharmaceutically acceptable 
salts thereof. Also provided are methods for preparing these compounds. These compounds are useful for 
inhibiting ERK1/2. By administering to a patient in need a therapeutically effective amount of one or more 
5 of the compounds of formula (I), wherein X, Y, Z, J, M, and R' to R are defined herein, these compounds 
are effective in treating conditions associated with dysregulation of the RAS/RAF/MEK/ERK pathway. A 
variety of conditions can be Ireated using these compounds and include diseases which are characterized by 
abnormal cellular proliferation. In one embodiment, the disease is cancer.  
NNZR5 R 6 
HN Z N\ M /J-R 
R4 X:=y N 
o R3 
347
Patent AU-2020294291-A1 (AU)
Title: Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists
Inventor: DUONG TIEN T
IPC: A61P11/00
Filed: 2020-12-24
Abstract: PHENYL UREA ANALOGS AS FORMYL PEPTIDE RECEPTOR 1 (FPR1) 
SELECTIVE AGONISTS 
ABSTRACT 
The present disclosure relates to phenyl urea derivatives, processes for 
preparing them, pharmaceutical compositions containing them and their use as 
pharmaceuticals as modulators of the N-formyl peptide receptor (FPR), such as 
agonism of the FPR1 and/or FPR2 receptor, or selective agonism of the FPR1 
receptor relative to the FPR2 receptor.
Patent AU-2020299633-A1 (AU)
Title: Neurodegenerative disease therapies utilizing the skin-brain axis
Inventor: GALLEGO-PEREZ DANIEL
IPC: C12N15/113
Filed: 2020-07-02
Abstract: As disclosed herein, the skin can dispatch signals to the brain in the form of exosomes, referred to herein as a "skin-brain axis." Therefore, disclosed herein is a method for diagnosing a brain disease, disorder, or injury in a subject that involves isolating exosomes from the subject and assaying the exosomes for the presence of one or more biomarkers of the disease, disorder, or injury. Also disclosed are methods of treating a subject with a brain disease, disorder, or injury that involves engineering the skin of the subject to produce therapeutic exosomes. Also disclosed are methods of collecting skin-produced exosomes and loading them with therapeutic cargo that can treat one or more diseases, disorders, or injuries of the brain. Also disclosed herein is a method to reduce exosomal release from the skin to reducing trafficking to the brain.
Patent AU-2020302708-A1 (AU)
Title: UE assisted fast transition between RRC states
Inventor: HE LINHAI
IPC: H04W76/27
Filed: 2020-06-18
Abstract: UEs may want to switch to the RRC idle state or to the RRC inactive state sooner than the expiration of the timer or without having to wait for the network to release the RRC connection. Allowing the UE to increase the rate at which it transitions to RRC idle state or RRC inactive state may allow the UE to reduce power consumption, as well as reduce signaling resources. The apparatus determines a preference between a transition to an RRC inactive state or to an RRC idle state when an RRC connection is released. The apparatus sends, to a base station, an RRC state preference indication of the preference for transitioning upon release of the RRC connection from the RRC connected state to one of the RRC inactive state or to the RRC idle state.
Patent AU-2020325831-A1 (AU)
Title: Infusion dosage form of norepinephrine
Inventor: KUMAR SAMARTH
IPC: A61K9/08
Filed: 2020-08-10
Abstract: The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.
Patent AU-2020330562-A1 (AU)
Title: Process to make calcium oxide or ordinary portland cement from calcium bearing rocks and minerals
Inventor: FINKE CODY E
IPC: C04B7/06
Filed: 2020-08-13
Abstract: Aspects of the invention include a method of producing a cement material comprising step of: first reacting a calcium-bearing starting material with a first acid to produce an aqueous first calcium salt; second reacting the aqueous first calcium salt with a second acid to produce a solid second calcium salt; wherein the second acid is different from the first acid and the second calcium salt is different from the first calcium salt; and thermally treating the second calcium salt to produce a first cement material. Preferably, but not necessarily, during the second reacting step, reaction between the first calcium salt and the second acid regenerates the first acid.
Patent AU-2020336465-A1 (AU)
Title: Rebounding device for sports ball
Inventor: FEDON SHANE
IPC: A63B63/00
Filed: 2020-08-28
Abstract: A rebounding device for sports balls including a frame defining a frame opening, a net disposed within the frame opening, a cable extending around a perimeter of the net and a cable tensioning system configured to tension the cable around the perimeter of the net and thereby pull the net taut within the frame opening.
Patent AU-2020349592-A1 (AU)
Title: Imaging and therapeutic compositions
Inventor: DONNELLY PAUL STEPHEN
IPC: C07C49/593
Filed: 2020-09-18
Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging and therapeutic agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
Patent AU-2020353217-A1 (AU)
Title: Treatment involving therapeutic antibody and interleukin-2 (IL2)
Inventor: SAHIN UGUR
IPC: A61K39/00
Filed: 2020-09-22
Abstract: Tumor cells often evade an immune response, e.g., by reducing or eliminating MHC expression and/or IFN-signaling, which enables uncontrolled growth. We demonstrate herein that antibody-based immunotherapy in combination with IL2 administration is an effective therapy against such resistant tumors. Specifically, the present disclosure relates to methods of treating a subject with cancer that is at least partially resistant to an MHC-dependent T cell response comprising administering to the subject: a. a polypeptide comprising IL2 or a functional variant thereof or a polynucleotide encoding a polypeptide comprising IL2 or a functional variant thereof; and b. antibody-based immunotherapy.
Patent AU-2020358044-A1 (AU)
Title: Translation load instruction
Inventor: WILLIAMS DEREK
IPC: G06F12/10
Filed: 2020-09-25
Abstract: A processor core processes a translation load instruction including a protection field specifying a desired access protection to be specified in a translation entry for a memory page. Processing the translation load instruction includes calculating an effective address within the memory page and ensuring that a translation entry containing the desired access protection is stored within at least one translation structure of the data processing system.
Patent AU-2020363975-A1 (AU)
Title: RAN proteins as biomarkers in CAG/CTG expansion disorders
Inventor: RANUM LAURA
IPC: G01N33/68
Filed: 2020-10-09
Abstract: Aspects of the disclosure relate to methods and compositions (e.g., kits) for detecting certain repeat-associated non-ATG (RAN) proteins in a subject (e.g., a subject having or suspected of having a disease associated with a CAG and/or CTG repeat expansion). In some embodiments, methods described by the disclosure comprise detecting one or more RAN proteins in a biological sample obtained from a subject by an immunoassay using one or more antibodies that target homopolymeric repeat regions of RAN proteins. In some embodiments, the disclosure relates to kits comprising one or more antibodies that target homopolymeric repeat regions of RAN proteins, and an immunoassay plate and/or reagents. In some embodiments, the disclosure provides methods of producing anti-RAN protein antibodies.
Patent AU-2020383933-A1 (AU)
Title: Devices and methods for checking battery state of health
Inventor: JAWIDZIK GEOFFREY C
IPC: G05G1/30
Filed: 2020-11-09
Abstract: Devices and methods are disclosed for checking the state of health of rechargeable batteries. An electronic device comprises a plurality of rechargeable batteries and a controller, wherein the controller comprises a battery fuel gauge for performing a battery state of health check. The controller is configured to direct charge to connected loads and to transfer charge from the battery being checked to another battery during a battery state of health check. An example method comprises charging one battery to a full state, leaving another battery in a depleted state, and performing a state of health check on the battery in the full state while transferring charge via an intermediate controller from the battery in the full state to the battery in the depleted state.
Patent AU-2020392975-A1 (AU)
Title: Nanosecond non-destructively erasable magnetoresistive random-access memory
Inventor: REZNICEK ALEXANDER
IPC: H01L43/12
Filed: 2020-10-23
Abstract: An erasable magnetoresistive random-access memory (MRAM) structure and a method of making the same includes an MRAM cell disposed between bit line and word line circuit elements, and a vertical-cavity surface-emitting laser (VCSEL) element disposed above the MRAM cell. A laser output of the VCSEL is directed toward the MRAM cell.
Patent AU-2020478565-A1 (AU)
Title: Floor cleaning device
Inventor: VALLAR RAMON MANOLO
IPC: A47L13/51
Filed: 2020-11-25
Abstract: A floor cleaning device (1) comprising a stick (2) with a cleaning head (3) at one end thereof; a lower tank (6); an upper tank (9) mounted inside and/or above the lower tank (6) and designed to contain a cleaning liquid; and a basket (18) adapted to receive the cleaning head (3) to be rinsed and carried by the upper tank (9) to move between a rest position, in which the basket (18) fluidically separates the upper tank (9) and the lower tank (6), and an operating position, in which the basket (18) fluidically connects the upper tank (9) with the lower tank (6) to allow the cleaning liquid to flow from the upper tank (9) to the lower tank (6) through the basket (18) so as to rinse the cleaning head (3) inside the basket (18).
Patent WO-2022174278-A1 (WO)
Inventor: WARDA SHAMERAN
IPC: G06Q50/08
Filed: 2021-02-18
Abstract: Building system with method of data gathering from various sources (52) in various categories (53), data interaction providing enhanced search results and building characteristic management resulting in effective building, material product data and building characteristic values. Use of the data on defragmentation of a building design (45) into subsets such as 71 to 84 and assessment of the individual subset and then the relative effect of one subset on adjacent subset so as to provide a whole effect of building characteristic values on the reconfigured building design (45) and building construction.
Patent WO-2021237309-A1 (WO)
Title: Multi-stimuli responsive metal-organic frameworks
Inventor: HALL LYNDON
IPC: C07D409/14
Filed: 2021-05-28
Abstract: This invention relates to multi-stimuli responsive metal-organic frameworks (MOFs) comprising a repeat unit of the formula M2(L1)2(L2)2. Also disclosed are methods of preparation of multi-stimuli responsive MOFs of the formula M2(L1)2(L2)2 as well as their uses.
Patent WO-2022006617-A1 (WO)
Title: Method and apparatus for dosing dry polymers using water soluble wax polymer blocks
Inventor: WILLIAMS DAVID
IPC: B01F1/00
Filed: 2021-06-02
Abstract: A dosing apparatus (10) for housing polymer blocks (12) comprises an elongate vessel (14) adapted to be connected in an inline flow system (16). The vessel (14) comprises a cylindrical wall (18) enclosed at each end to form a sealed flow path for liquid. A bottom end plate (20) is provided at a lower end of the cylindrical wall (18), the bottom end plate (20) having a liquid exit port (22) of the vessel (14) provided therein. A top end plate (24) is provided at an upper end of the cylindrical wall (18), the top end plate having a removable lid (26) provided in connection therewith. The removable lid (26) has a liquid entry port (28) of the vessel (14) provided therein. One or more polymer blocks (12) may be inserted into the vessel (14) by removing and replacing the lid (26). A liquid inlet pipe of the inline flow system (16) is connected to the liquid entry port (28), and a liquid outlet pipe is connected to the liquid exit port (22) of the vessel (14). In use, as liquid flows through the vessel (14), polymer from the polymer block (12) is dispersed into the liquid at a controlled rate as the polymer block (12) begins to dissolve.
Patent AU-2021200352-A1 (AU)
Title: Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
Inventor: GOODACRE SIMON CHARLES
IPC: A61P35/00
Filed: 2021-01-20
Abstract: Described herein are tetrahydro-pyrido[3,4-b]indol-1-yl compounds with estrogen 
receptor modulation activity or function having the Formula I structure: 
R 3 R4 
N-R 5 
N Z 1 -Cy R1 R2 
(R6 )m z2 -y 1  y 3 
~y2' 
and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the 
substituents and structural features described herein. Also described are pharmaceutical 
compositions and medicaments that include the Formula I compounds, as well as methods of 
using such estrogen receptor modulators, alone and in combination with other therapeutic 
0 agents, for treating diseases or conditions that are mediated or dependent upon estrogen 
receptors.
Patent AU-2021200994-A1 (AU)
Title: Systems and methods for determining space availability in an aircraft
Inventor: PATEL AMAR
IPC: G01F17/00
Filed: 2021-02-16
Abstract: An example system (140) for determining space availability in an aircraft (140) includes a 
plurality of laser sensors (150) configured to be positioned in a baggage container (154) at a first 
wall (156) and a second wall (158), and the first wall and the second wall face each other. The 
plurality of laser sensors emit signals (188) within the baggage container and detect reflected 
responses (210) to generate outputs (211). The system also includes one or more processors (160) 
in communication with the plurality of laser sensors for executing instructions (162) stored in non
transitory computer readable media (164) to perform functions including receiving (252) the outputs 
from the plurality of laser sensors, mapping (254) contents of the baggage container based on the 
outputs from the plurality of laser sensors, and based on said mapping, outputting (256) data (212) 
indicative of occupied space in the baggage container.
5/8 
180a 196 15 80b 
180b 
188 195lk192 8 
210 18620 
6017 
188 206 211